Skripsi
KERJA SAMA JEPANG-INDONESIA DALAM BANTUAN VAKSIN COVID-19 DI INDONESIA
The Covid-19 pandemic is the beginning of a slump for countries like what happened in Indonesia. This pandemic started with the spread of a pneumonia outbreak in Wuhan City, China in December 2019. In order to minimize the spread of Covid-19, Indonesia made many efforts and policies to break the chain of Covid-19 distribution. The Indonesian government has made progressive efforts such as limiting community activities outside the home, school activities, work and worship. Another thing that the government has done is to distribute the use of vaccines, especially for medical personnel and people who often work outside. One way to expedite the distribution of vaccines so that they are evenly distributed among the Indonesian people is that Indonesia cooperates with Japan. Japan provided assistance in the form of vaccines for Indonesia, which collected 2.1 million vaccines and 998,400 vaccines have arrived in Indonesia. The vaccine has been produced by the Daiichi Sankyo Biotech Cooperation company from Japan. This study describes the Japan-Indonesia Cooperation in Covid-19 Assistance in Indonesia. Using the framework of the concept of Global Health Diplomacy. Judging from the elements of Institutions and Actors, Policy Environment, and Issue Characteristics
Inventory Code | Barcode | Call Number | Location | Status |
---|---|---|---|---|
2207003486 | T77788 | T777882022 | Central Library (Referens) | Available |
No other version available